The Relationship of Pregnancy-Associated Plasma Protein A and Human Chorionic Gonadotropin with Adverse Pregnancy Outcomes: A Prospective Study
Authors:
- 11 April 2019
- journal article
- research article
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 69 (5) , 412-419
Abstract
Purpose This prospective study investigated the relationship between pregnancy-associated plasma protein A (PAPP-A) and human chorionic gonadotropin (hCG) and adverse pregnancy outcomes in the Iranian population. Materials Overall, 994 singleton pregnant mothers of 18–35-year old were referred for first-trimester screening tests, including PAPP-A and β-hCG, at the age of 6 days and 11–13 weeks, and were followed until the end of their pregnancy. The adverse pregnancy outcomes, PAPP-A, and β-hCG serum levels were recorded and analyzed. The sensitivity and specificity of the test were measured by calculating the area under the curve of receiver operating characteristic curve (ROC). Results The mean serum level of PAPP-A and β-hCG was 1.10 ± 0.69 and 1.09 ± 0.8 MoM, respectively. Pregnancy-associated plasma protein A, regardless of its percentile, showed a significant relationship with the incidence of preeclampsia, preterm birth, and fetal low birth weight (p < 0.001 for each). However, the relationship between PAPP-A and abortion was not significant (p > 0.05). According to ROC, the results indicated that PAPP-A had a significant relationship with the incidence of preeclampsia, preterm birth, and fetal low birth weight (p < 0.001). However, β-hCG levels showed no significant relationship with adverse pregnancy outcomes. Conclusions The result of this study revealed that lower level of PAPP-A and β-hCG could be a predictive factor in preterm labor. Also, this study indicated that PAPP-A measurements could be a screening test for adverse pregnancy outcomes, such as preeclampsia, low birth weight and preterm labor.Keywords
This publication has 41 references indexed in Scilit:
- First-Trimester Levels of Pregnancy-Associated Plasma Protein A2 (PAPP-A2) in the Maternal Circulation Are Elevated in Pregnancies That Subsequently Develop PreeclampsiaReproductive Sciences, 2014
- Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysisBMJ, 2013
- Plasma MIC-1 and PAPP-A Levels Are Decreased among Women Presenting to an Early Pregnancy Assessment Unit, Have Fetal Viability Confirmed but Later MiscarryPLOS ONE, 2013
- Association between first‐trimester maternal serum pregnancy‐associated plasma protein‐A and obstetric complicationsPrenatal Diagnosis, 2013
- First‐trimester prediction of preterm birth using ADAM12, PAPP‐A, uterine artery Doppler, and maternal characteristicsPrenatal Diagnosis, 2012
- PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia?ISRN Obstetrics and Gynecology, 2012
- Perinatal Outcomes of Southeast Asians with Pregnancies Complicated by Gestational Diabetes Mellitus or PreeclampsiaJournal of Immigrant and Minority Health, 2011
- Decreased PAPP-A is associated with preeclampsia, premature delivery and small for gestational age infants but not with placental abruptionEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
- Prediction of Small-for-Gestation Neonates from Biophysical and Biochemical Markers at 11–13 WeeksFetal Diagnosis and Therapy, 2010
- PAPP‐A, free β‐hCG, and early fetal growth identify two pathways leading to preterm deliveryPrenatal Diagnosis, 2010